66308 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2023-02-28 |
| Register Year | 2017 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | ACLIDINIUM BROMIDE |
| Trade Name | EKLIRA GENUAIR 322 mcg INHALATION POWDER |
| Strength Unit | µg |
| Pharmaceutical Form | Inhalation powder |
| Administration Route | Inhalation use |
| Atc Code1 | R03BB05 |
| Atc Code2 | |
| Size | 60 |
| Size Unit | DF |
| Package Types | Inhaler |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Pharmacy |
| Public price | $125.7 |
| Shelf Life | 36 Months |
| Marketing Company | AstraZeneca |
| Marketing Country | Sweden |
| Manufacture Name | INDUSTRIAS FARMACEUTICAS ALMIRALL, S.A |
| Manufacture Country | Spain |
| Secondry package manufacture | |
| Main Agent | SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO) |
| Secosnd Agent | |
| Third Agent | |
| Visits | 66308 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| EKLIRA GENUAIR 322 mcg INHALATION POWDER | $125.7 | 66308 visits | 2023-02-28 |